Product
Silmitasertib
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Phase II, Randomized, Investigator Initiated Trial to Evaluate Safety and to Explore Clinical Benefit of Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)Status: Terminated, Estimated PCD: 2022-06-30